Showing results (261-270 of 499) with videos related to

Sort By:
Pageof 50
Biopharmaceutics & Drug Disposition|March 23, 1999
Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1D C Dimmitt, Y S Choo, L A Martin, et al.
Human Molecular Genetics|March 4, 2000
Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS ratP M D'Cruz, D Yasumura, J Weir, et al.
Trials|July 19, 2019
Correction to: Promoting Recruitment using Information Management Efficiently (PRIME): study protocol for a steppedwedge cluster randomised controlled trial within the REstart or STop Antithrombotics Randomised Trial (RESTART)Amy E Maxwell, Martin Dennis, Anthony Rudd, et al.
Plos One|October 4, 2018
The acute medical unit model: A characterisation based upon the National Health Service in ScotlandLindsay E M Reid, Ursula Pretsch, Michael C Jones, et al.
The British Journal of Radiology|September 1, 1989
Low-field (0.08 T) magnetic resonance imaging of the pancreas: comparison with computed tomography and ultrasoundF W Smith, A P Bayliss, J K Hussey, et al.
Journal of Hypertension|December 1, 1995
Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and strokeS Ueda, C J Weir, G C Inglis, et al.
European Journal of Neurology|June 17, 2005
Statin administration prior to ischaemic stroke onset and survival: exploratory evidence from matched treatment-control studyS Aslanyan, C J Weir, G T McInnes, et al.
Trials|March 2, 2017
Promoting Recruitment using Information Management Efficiently (PRIME): study protocol for a stepped-wedge cluster randomised controlled trial within the REstart or STop Antithrombotics Randomised Trial (RESTART)Amy E Maxwell, Martin Dennis, Anthony Rudd, et al.
Biopharmaceutics & Drug Disposition|March 23, 1999
Single- and multiple-dose pharmacokinetics of oral dolasetron and its active metabolites in healthy volunteers: part 2D C Dimmitt, Y S Choo, L A Martin, et al.
Statistical Methods in Medical Research|October 2, 2015
Development of a Bayesian response-adaptive trial design for the Dexamethasone for Excessive Menstruation studyChristian Holm Hansen, Pamela Warner, Richard A Parker, et al.
Pageof 50